E-LIB Suche - Ergebnisse für: Preskorn, S.

1

2 Dexmedetomidine Sublingual Film for Acute Agitation in Sc..:

Citrome, L. ; Preskorn, S. ; Watson, C...
Annals of Emergency Medicine. 80 (2022) 4 - p. S1-S2 , 2022

Link: https://doi.org/10.1016/..

2

PMH7 LIKELIHOOD OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG P..:

Valuck, R.J. ; Libby, A.M. ; Anderson, H.D....
Value in Health. 14 (2011) 3 - p. A186 , 2011

Link: https://doi.org/10.1016/..

3

Assessing the pharmacokinetics of venlafaxine ER 75mg and d..:

Kane, C. ; Nichols, A. ; Focht, K....
Journal of Affective Disorders. 122 (2010) - p. S62 , 2010

Link: https://doi.org/10.1016/..

4

P.2.c.037 Assessing the pharmacokinetics of venlafaxine er ..:

Kane, C. ; Nichols, A. ; Focht, K....
European Neuropsychopharmacology. 19 (2009) - p. S425 , 2009

Link: https://doi.org/10.1016/..

5

P.2.b.013 A comparison of the pharmacokinetics of venlafaxi..:

Preskorn, S. ; Patroneva, A. ; Nichols, A....
European Neuropsychopharmacology. 17 (2007) - p. S339 , 2007

Link: https://doi.org/10.1016/..

6

P.3.c.050 Effect of asenapine versus quetiapine and placebo..:

Preskorn, S. ; Chapel, S. ; Panagides, J.
European Neuropsychopharmacology. 17 (2007) - p. S453 , 2007

Link: https://doi.org/10.1016/..

7

P.3.c.067 Effect of meal size and fat content on oral zipra..:

Preskorn, S. ; Lombardo, I. ; Alderman, J....
European Neuropsychopharmacology. 17 (2007) - p. S463 , 2007

Link: https://doi.org/10.1016/..

8

PII-63The effect of duloxetine, escitalopram, and sertralin..:

PRESKORN, S ; BAKER, B ; KLICKDAVIS, A...
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P52-P52 , 2006

Link: https://doi.org/10.1016/..

9

The potential for clinically significant drug-drug interact..:

Preskorn, S
Clinical Pharmacology & Therapeutics. 75 (2004) 2 - p. P71 , 2004

Link: https://doi.org/10.1016/..

10

P.1.127 The potential for clinically significant drug-drug ..:

Preskorn, S. ; Shah, R. ; Silkey, B....
European Neuropsychopharmacology. 13 (2003) - p. S228 , 2003

Link: https://doi.org/10.1016/..

11

The nature and extent of polypharmacy in patients on antide..:

SHAD, M ; CARMICHAEL, C ; PRESKORN, S.
Clinical Pharmacology & Therapeutics. 65 (1999) 2 - p. 183-183 , 1999

Link: https://doi.org/10.1016/..

12

Use of population pharmacokinetic modeling to characterize ..:

SHAD, M ; PRESKORN, S ; MICELI, J.
Clinical Pharmacology & Therapeutics. 65 (1999) 2 - p. 171-171 , 1999

Link: https://doi.org/10.1016/..

13

Pharmacokinetics of intramuscular ziprasidone in schizophre..:

Miceli, J. ; Wilner, K. ; Folger, C...
European Neuropsychopharmacology. 8 (1998) - p. S215 , 1998

Link: https://doi.org/10.1016/..

14

P.1.097 The clinical relevance of the cytochrome P450 enzym..:

Preskorn, S.
European Neuropsychopharmacology. 7 (1997) - p. S165-S166 , 1997

Link: https://doi.org/10.1016/..

15

P-178 Primary care evaluation of mental disorders (PRIME-MD..:

Wright, S ; Grainger, D ; Tjaden, B.
Fertility and Sterility. 68 (1997) - p. S178-S179 , 1997

Link: https://doi.org/10.1016/..